IRIS
POLONI, Antonella
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 10.197
EU - Europa 5.714
AS - Asia 5.029
SA - Sud America 1.392
AF - Africa 314
Continente sconosciuto - Info sul continente non disponibili 19
OC - Oceania 14
AN - Antartide 1
Totale 22.680
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 10.042
SG - Singapore 1.530
VN - Vietnam 1.178
BR - Brasile 1.094
IT - Italia 1.084
RU - Federazione Russa 1.004
CN - Cina 798
UA - Ucraina 789
DE - Germania 504
IE - Irlanda 482
SE - Svezia 438
HK - Hong Kong 415
FR - Francia 338
TR - Turchia 335
FI - Finlandia 302
DK - Danimarca 290
GB - Regno Unito 218
KR - Corea 166
IN - India 152
CI - Costa d'Avorio 115
AR - Argentina 100
BD - Bangladesh 76
MA - Marocco 76
NL - Olanda 66
MX - Messico 65
IQ - Iraq 63
CA - Canada 61
JP - Giappone 52
PL - Polonia 48
CO - Colombia 46
ZA - Sudafrica 45
AT - Austria 41
EC - Ecuador 39
ID - Indonesia 38
VE - Venezuela 37
PK - Pakistan 31
UZ - Uzbekistan 31
BE - Belgio 24
ES - Italia 24
PY - Paraguay 24
TN - Tunisia 23
CL - Cile 21
EU - Europa 19
AE - Emirati Arabi Uniti 18
PH - Filippine 16
DZ - Algeria 15
PE - Perù 15
AU - Australia 13
AZ - Azerbaigian 12
KE - Kenya 12
MY - Malesia 12
SA - Arabia Saudita 12
EG - Egitto 11
JO - Giordania 11
IL - Israele 9
UY - Uruguay 9
CH - Svizzera 8
BG - Bulgaria 7
IR - Iran 7
KZ - Kazakistan 7
TW - Taiwan 7
BH - Bahrain 6
CZ - Repubblica Ceca 6
DO - Repubblica Dominicana 6
LB - Libano 6
LT - Lituania 6
TH - Thailandia 6
AL - Albania 5
BO - Bolivia 5
CR - Costa Rica 5
SN - Senegal 5
HN - Honduras 4
KG - Kirghizistan 4
KW - Kuwait 4
MN - Mongolia 4
NP - Nepal 4
OM - Oman 4
PS - Palestinian Territory 4
RO - Romania 4
BZ - Belize 3
GA - Gabon 3
GT - Guatemala 3
HR - Croazia 3
HU - Ungheria 3
MD - Moldavia 3
PT - Portogallo 3
EE - Estonia 2
ET - Etiopia 2
GY - Guiana 2
MT - Malta 2
QA - Qatar 2
RS - Serbia 2
SY - Repubblica araba siriana 2
AQ - Antartide 1
BA - Bosnia-Erzegovina 1
BJ - Benin 1
BN - Brunei Darussalam 1
BY - Bielorussia 1
CG - Congo 1
CY - Cipro 1
Totale 22.655
Salva come PNG Salva come JPEG
Città #
Ashburn 1.385
Singapore 922
Jacksonville 821
Chandler 752
Fairfield 619
Dallas 585
Dublin 482
Boardman 467
Hong Kong 396
Ho Chi Minh City 395
San Jose 392
Des Moines 337
Wilmington 331
New York 314
Hanoi 271
Houston 250
Seattle 237
The Dalles 231
Woodbridge 209
Lauterbourg 195
Beijing 194
Los Angeles 189
Lawrence 182
Princeton 182
San Mateo 176
Moscow 167
Cambridge 147
Ann Arbor 129
Hefei 125
Helsinki 120
Abidjan 115
Chicago 113
Centro 112
São Paulo 83
Ancona 80
San Diego 78
Munich 74
Redmond 74
Buffalo 71
Milan 66
Orem 66
Turin 65
Rome 61
Council Bluffs 59
Da Nang 57
Haiphong 56
Marche 46
London 43
Salt Lake City 43
Pune 41
Denver 38
Guangzhou 37
Santa Clara 36
Shanghai 36
Frankfurt am Main 34
Porto 33
Warsaw 33
Nuremberg 31
Tokyo 31
Amsterdam 30
Chennai 28
Montreal 27
Norwalk 27
Pianella 27
Tashkent 27
Turku 27
Stockholm 26
Washington 26
Johannesburg 25
Rio de Janeiro 25
Brooklyn 24
Phoenix 24
Vienna 23
Atlanta 22
Baghdad 21
Brussels 21
Belo Horizonte 20
Biên Hòa 19
Columbus 19
Elk Grove Village 19
Poplar 19
Boston 18
Brasília 18
Medellín 18
Mexico City 18
Mumbai 18
Naples 18
Hải Dương 17
Curitiba 16
Tampa 16
Can Tho 14
Falconara Marittima 14
Hangzhou 14
Lahore 14
Manchester 14
Toronto 14
Wuhan 14
Porto Alegre 13
Ankara 12
Baku 12
Totale 13.732
Salva come PNG Salva come JPEG
Nome #
The Time Has Come for Targeted Therapies for AML: Lights and Shadows 376
Algoritmi diagnostico-terapeutici in Ematologia 303
Human white adipocytes convert into “rainbow” adipocytes in vitro 259
A novel method to evaluate prethawing viability of cryopreserved CD34+ hematopoietic stem cells for autologous transplantation. 219
Human de-differentiated adipocytes show similar properties to bone marrow derived mesenchymal stem cells 214
Feasibility and Outcome of a Phase II Study of Intensive Induction Chemotherapy in 91 Elderly Patients with AML Evaluated Using a Simplified Multidimensional Geriatric Assessment 208
Apoptotic mechanism activated by blue light and cisplatinum in cutaneous squamous cell carcinoma cells 203
Serum Inflamma-miR Signature: A Biomarker of Myelodysplastic Syndrome? 199
Low-dose Gemtuzumab-Ozogamicin as post-consolidation therapy in elderly patients with acute myeloid leukaemia: a pilot study. 186
Eltrombopag versus placebo for low-risk myelodysplastic syndromes with thrombocytopenia (EQoL-MDS): phase 1 results of a single-blind, randomised, controlled, phase 2 superiority trial. 182
Immunomodulatory Effects of Tyrosine Kinase Inhibitor In Vitro and In Vivo Study 179
Conditioning regimen with beam plus amifostine for outpatient autologous stem cell tansplantation: feasibility and outcome in 97 lymphoma patients. 173
Adipocytes properties and crosstalk with immune system in obesity-related inflammation. 173
Glial-like differentiation potential of human mature adipocytes 166
In vitro comparison of different TKI activity in T-Cell populations: selective sparing of Treg by Nilotinib. 163
Nilotinib Treatment of Patients Affected by Chronic Graft-versus-Host Disease Reduces Collagen Production and Skin Fibrosis by Downmodulating the TGF-β and p-SMAD Pathway 159
Gene expression profile of cytokines in patients with chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation with reduced conditioning. 158
Mobilization-Driven Postconsolidation Therapy in Elderly Patients with Acute Myeloid Leukemia: Feasibility and Efficacy of Autologous Stem Cell Transplantation versus Low-Dose Gemtuzumab Ozogamicin 156
Efficacy and feasibility of high-dose cytarabine plus idarubicin and amifostine as induction schedule: a prospective observational study of 100 AML elderly patients 154
Acute promyelocyte leukemia arose from CALR 1 mutated post essential thrombocythemia- myelofibrosis with splanchnic vein thrombosis: A case report 154
A Combination of Lenalidomide and Rituximab (ReRi) As Salvage Therapy in Elderly Patients Affected By Diffuse Large B Cells (DLBCL) Lymphoma Relapsed and Refractory 153
Human bone marrow adipocytes maintain the survival and differentiation of hematopoietic stem cells 152
Bone marrow adipose tissue is a unique adipose subtype with distinct roles in glucose homeostasis 152
Azacitidine Treatment in High Risk Myelodysplastic Patients in Complete Haematological Remission Reverts Mesenchymal Stem Cells to a Normal Phenotype 150
Shaping the Future of Myeloproliferative Neoplasm Therapy: Immune-Based Strategies and Targeted Innovations 148
A real life survey on erytropoietin alpha treatment in a cohort of 1049 low risk MDS patients: an italian MDS registry study 147
Stimulatory autoantibodies to PDGF receptor in patients with extensive chronic graft-versus-host disease 147
A new schedule of CHOP/rituximab plus granulocyte-macrophage colony-stimulating factor is an effective rescue for patients with aggressive lymphoma failing autologous stem cell transplantation. 147
Thalidomide, dexamethasone, and pegylated liposomal doxorubicin (ThaDD) for patients older than 65 years with newly diagnosed multiple myeloma. 147
A 50 Hz magnetic field influences the viability of breast cancer cells 96 h after exposure 145
Low FasL levels promote proliferation of human bone marrow-derived mesenchymal stem cells, higher levels inhibit their differentiation into adipocytes. 144
Aging- and Senescence-associated Changes of Mesenchymal Stromal Cells in Myelodysplastic Syndromes 142
The exosomal surface phenotype and inflamma-miR cargo correlate with MDS diagnosis 142
Amifostine can reduce mucosal damage after high-dose melphalan conditioning for peripheral blood progenitor cell autotransplant: a retrospective study 141
Biosafety evidence for human dedifferentiated adipocytes 141
Prognostic role of immunohistochemical analysis of 5 mc in myelodysplastic syndromes. 138
The Exaggerated Collagen Expression in Gvhd-Fibroblasts Is Effectively Inhibited By Therapeutic Concentration of Nilotinib 138
Gemtuzumab-Ozogamicin as Post-Consolidation Therapy In Elderly Patients with Acute Myeloid Leukemia: a Pilot Study 137
A new intensive induction schedule, including high-dose Idarubicin, high-dose Aracytin and Amifostine, in older AML patients: feasibility and long-term results in 42 patients. 136
Cytokine expression profile of selected cell populations from patients with chronic graft-versus-host disease after allogeneic bone marrow transplantation wih reduced conditioning. 136
A phase II, multicentre trial of decitabine in higher-risk chronic myelomonocytic leukemia 136
Plasticity of human dedifferentiated adipocytes toward endothelial cells 135
Human AB serum for generation of mesenchymal stem cells from human chorionic villi: comparison with other source and other media including platelet lysate 135
LATE EFFECTS IN Hodgkin's POPULATION Treated BETWEEN 1980-2005 IN A SINGLE INSTITUTION 135
A rare case of aCML associated with CNS involvement and with aggressive clinical course 135
High predictive value of the revised international prognostic scoring system (IPSS-R): an external analysis of 646 patients from a multiregional italian MDS registry 134
Hematologic reconstitution after PBPC autotransplantation:comparison between programmed-rate freezing and uncontrolled freezing at –80° 133
Human Mesenchymal Stem Cells from chorionic villi and amniotic fluid are not susceptible to transformation after extensive in vitro expansion 133
Transfusion independence after lenalidomide discontinuation in patients with del(5q) myelodysplastic neoplasm: a HARMONY Alliance study 132
MiR-422a promotes adipogenesis via MeCP2 downregulation in human bone marrow mesenchymal stem cells 132
Tailored Therapy in an Unselected Population of 91 Elderly Patients with DLBCL Prospectively Evaluated Using a Simplified CGA. 130
Bone marrow adipocytes support haematopoietic stem cell survival 130
Preventive Effects of Cardotoxicities By Liposomal Anthracyclines non Pegilated in 95 Perspective Patients Affected By Lymphoma and Monitored By Biomarkers and Ecocardiography 129
Screening of psychological distress in oncology and hematology department at Ospedali Riuniti Ancona 126
LA POSITIVITÀ DEL WT1 POST-INDUZIONE È UN IMPORTANTE FATTORE PROGNOSTICO PREDITTIVO DI RECIDIVA PRECOCE IN UNA CASISTICA DI 80 PAZIENTI AFFETTI DA LEUCEMIA ACUTA MIELOIDE 125
Bone Marrow "Yellow" and "Red" Adipocytes: Good or Bad Cells? 124
Iron overload alters the energy metabolism in patients with myelodysplastic syndromes: results from the multicenter FISM BIOFER study 124
A new schedule of CHOP/rituximab plus granulocyte-macrophage colony-stimulating factor is an effective rescue for patients with aggressive lymphoma failing autologous stem cell trasplantation 123
Hematologic reconstitution after PBPC autotransplantation: comparison between programmed-rate freezing and uncontrolled-rate freezing at -80 degrees C 123
Overexpression of CDKN2B (p15INK4B) and altered global DNA methylation status in mesenchymal stem cells of high-risk myelodysplastic syndromes 123
Targeting the immune system in MDS and MPN: Understanding the immunome and response to immunotherapy - Part 2 122
Molecular and functional characterization of human bone marrow adipocytes 122
History and scientific production of clinica medica and clinica ematologica in ancona 121
Long-term outcome and prospective validation of NIH response criteria in 39 patients receiving imatinib for steroid-refractory chronic GVHD 120
Uncommon Presentation of Sarcoidosis with Severe Thrombocytopenia and Hemorrhagic Diathesis 119
Interaction between human mature adipocytes and lymphocytes induces T-cell proliferation 119
Molecular Pathogenesis of Myeloproliferative Neoplasms: From Molecular Landscape to Therapeutic Implications 119
NOVELTIES ON MULTIPLE MYELOMA FROM THE MAIN 2024 HEMATOLOGY CONFERENCES 118
Efficacy and safety of eltrombopag for the treatment of thrombocytopenia of low and intermediate-1 IPSS risk myelodysplastic syndromes: interim analysis of a prospective, randomized, single-blind, placebo-controlled trial (EQoL-MDS) 117
Patients with chronic extensive GvHD produce high levels of stimulatory auto-antibodies to the PDGF receptor: a new pathophysiological pathway of the disease progression 117
Selection of CD271(+) cells and human AB serum allows a large expansion of mesenchymal stromal cells from human bone marrow 115
Identification of different adypocytes populations within human marrow microenvironment 115
Bone Marrow Adipose Tissue 114
Accuracy of bone marrow histochemical TP53 expression compared to the detection of TP53 somatic mutations in patients with myelodysplastic syndromes harbouring a del5q cytogenetic abnormality 114
Combined administration of alpha-erythropoietin and filgrastim can improve the outcome and cost balance of autologous stem cell transplantation in patients with lymphoproliferative disorders. 113
ITACA: A new validated international erythropoietic stimulating agent-response score that further refines the predictive power of previous scoring systems 113
Biological activity of lenalidomide in myelodysplastic syndromes with del5q: results of gene expression profiling from a multicenter phase II study 112
Effects of erythropoiesis-stimulating agents on overall survival of International Prognostic Scoring System Low/Intermediate-1 risk, transfusion-independent myelodysplastic syndrome patients: a cohort study 112
mTOR and STAT3 Pathway Hyper-Activation is Associated with evated Interleukin-6 Levels in Patients with Shwachman-Diamond Syndrome: Further Evidence of Lymphoid Lineage Impairment 111
Novel Translational Read-Through–Inducing Drugs as A Therapeutic Option for Shwachman-Diamond Syndrome 111
AMIFOSTINE CAN REDUCE MUCOSAL DAMAGE AFTER HIGH-DOSE MELPHALANCONDITIONING FOR PERIPHERAL BLOOD PROGENITOR CELL AUTOTRANSPLANT: A RETROSPECTIVE STUDY. EFFECT OF AMIFOSTINE ON MUCOSITIS DURING AUTOLOGOUS PBPC TRANSPLANTATION 110
Mesenchymal stem cells of myelodysplastic syndromes show impaired hematopoietic support function and global DNA hypermethylation status 110
Characterization and expansion of mesenchymal progenitor cells from first-trimester chorionic villi of human placenta. 108
Reporting Guidelines, Review of Methodological Standards, and Challenges Toward Harmonization in Bone Marrow Adiposity Research. Report of the Methodologies Working Group of the International Bone Marrow Adiposity Society 107
Long duration of response to azacitidine in MDS. Multicenter retrospective study of 36 patients 105
CHANGES IN RPS14 EXPRESSION LEVELS DURING LENALIDOMIDE TREATMENT IN LOW- AND INTERMEDIATE-1-RISK MYELODYSPLASTIC SYNDROMES WITH CHROMOSOME 5Q DELETION 105
Chronic Myelomonocytic Leukemia Diagnosis By Flow Cytometry: An Italian Center Experience 104
DNA demethylating therapy reverts mesenchymal stromal cells derived from high risk myelodysplastic patients to a normal phenotype 104
Assessment and monitoring of CMV infection in patients receiving a reduced-intensity conditioning allogeneic transplant: comparison of antigenaemia assay with quantitative PCR 103
A Real Life Survey On Erythropoietin Alpha Treatment In a Cohort Of 1049 Low Risk MDS Patients: An Italian MDS Registry Study 103
Ataluren improves myelopoiesis and neutrophil chemotaxis by restoring ribosome biogenesis and reducing p53 levels in Shwachman-Diamond syndrome cells 102
Telomere length, c-myc and mad-1 expression could represent prognosis markers of myelodysplastic syndrome 101
TREATMENT WITH AZACITIDINE REVERSES MESENCHYMAL STEM CELLS DERIVED FROM HIGH RISK MYELODYSPLASTIC PATIENTS TO A NORMAL PHENOTYPE 101
OVEREXPRESSION OF CDKN2B IS ASSOCIATED WITH REDUCED PROLIFERATIVE POTENTIAL IN MESENCHYMAL STEM CELL FROM HIGH-RISK MYELODYSPLASTIC SYNDROME 101
Hepatic, gastric and bone marrow AL amyloidosis that began with Budd-Chiari syndrome: a case report 99
AL amyloidosis: an overview on diagnosis, staging system, and treatment 99
QUALITY OF LIFE ASSESSMENT IN PATIENTS AFFECTED BY MYELODYSPLASTIC SYNDROME 99
Engraftment capacity of mesenchymal cells following hematopoietic stem cell transplantation in patients receiving reduced-intensity conditioning regimen. 99
Bone Marrow Immunological Changes During Treatment with Lenalidomide In Low and Intermediate-1 Risk Myelodysplastic Syndromes with Del(5Q) 99
Novel Immunotherapies and Combinations: The Future Landscape of Multiple Myeloma Treatment 98
Totale 13.845
Salva come PNG Salva come JPEG
Categoria #
all - tutte 100.371
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 100.371
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021564 0 0 0 0 0 0 0 0 0 177 263 124
2021/20221.467 72 351 26 90 10 80 68 111 91 131 136 301
2022/20232.479 225 241 208 188 155 516 2 120 584 10 184 46
2023/20241.626 228 49 87 233 254 371 42 35 5 56 33 233
2024/20253.608 357 318 141 61 131 101 305 101 859 262 338 634
2025/20268.653 630 737 687 1.054 892 658 1.703 933 734 625 0 0
Totale 23.191